about
Early interventions in risk groups for schizophrenia: what are we waiting for?Predictors of outcome in early-onset psychosis: a systematic reviewVulnerability to omega-3 deprivation in a mouse model of NMDA receptor hypofunctionSpatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia.Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia.Detecting clinically significant events through automated language analysis: Quo imus?The association between antibodies to neurotropic pathogens and schizophrenia: a case-control study.Alterations in the hippocampus and thalamus in individuals at high risk for psychosis.Unravelling socio-motor biomarkers in schizophrenia.Effects of childhood and adolescence physical activity patterns on psychosis risk-a general population cohort studyThought disorder measured as random speech structure classifies negative symptoms and schizophrenia diagnosis 6 months in advanceAltered sulcogyral patterns of orbitofrontal cortex in a large cohort of patients with schizophrenia.Generating testable hypotheses for schizophrenia and rheumatoid arthritis pathogenesis by integrating epidemiological, genomic, and protein interaction dataDecreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patientsDopamine D2 receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances.Isoform specific differences in phospholipase C beta 1 expression in the prefrontal cortex in schizophrenia and suicideDNA methylation evidence against the accelerated aging hypothesis of schizophrenia.Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder-a systematic review of the magnetic resonance neuroimaging literature.DNA methylation in schizophrenia in different patient-derived cell types.Electroconvulsive therapy-induced brain functional connectivity predicts therapeutic efficacy in patients with schizophrenia: a multivariate pattern recognition studyDisturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules.Schizophrenia interactome with 504 novel protein-protein interactionsAutomated analysis of free speech predicts psychosis onset in high-risk youthsAbnormal hippocampal-thalamic white matter tract development and positive symptom course in individuals at ultra-high risk for psychosis.Spontaneous parkinsonisms and striatal impairment in neuroleptic free youth at ultrahigh risk for psychosis.Contribution of substantia nigra glutamate to prediction error signals in schizophrenia: a combined magnetic resonance spectroscopy/functional imaging study.Characterization of molecular and cellular phenotypes associated with a heterozygous CNTNAP2 deletion using patient-derived hiPSC neural cells.The relationship between dopamine receptor D1 and cognitive performanceThe proteome of schizophrenia.Relationship between somatostatin and death receptor expression in the orbital frontal cortex in schizophrenia: a postmortem brain mRNA study.A hopeful tale from the wonderland of psychosis.Voxel-based, brain-wide association study of aberrant functional connectivity in schizophrenia implicates thalamocortical circuitryMicrovascular dysfunction in schizophrenia: a case-control study.Anhedonia in the psychosis risk syndrome: associations with social impairment and basal orbitofrontal cortical activity.Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case-control studyFunctional magnetic resonance spectroscopy of glutamate in schizophrenia and major depressive disorder: anterior cingulate activity during a color-word Stroop task.Intraindividual neurophysiological variability in ultra-high-risk for psychosis and schizophrenia patients: single-trial analysis.Association between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case registerDoes environmental confounding mask pleiotropic effects of a multiple sclerosis susceptibility variant on vitamin D in psychosis?Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia.
P1433
Q26747545-6BF4D14D-E56A-4156-8371-25EC399EBDA4Q26859165-F7A8F4B5-0B78-4702-ACDC-CBCC83072CAAQ30355617-D7435C82-D53D-4121-8FA7-BD897AF7991AQ30355619-5BA064F1-AECF-400D-A2B9-B3C43BC787F8Q30365000-4E52FF81-87E9-40BB-8CB2-B586FCB18DBEQ30381093-D54495E7-33E3-4E7A-B094-DD65405D9FE3Q30381097-459E5EE5-F1E8-4F8B-AFC2-7E033387A943Q30381309-780D954E-4F94-48F0-A512-6F52791EC845Q30852780-96662993-5599-4AE9-8ACC-A8579CFEB0F1Q30852787-38395B67-4922-46C5-882B-47ECC9085301Q30852795-F1F2EC92-B069-46A0-A282-0C53FC63B1CAQ33718780-831D998A-AB7F-450B-8E1D-FF9BAF301C6BQ33718785-2F71A6AA-8F72-4F59-B408-853A61A7AE15Q33718794-5CEE41BE-BCD8-46EF-ADA7-EE21765F39EAQ33718801-FFA08603-F665-4419-86F9-38E5F9AC95CCQ33718808-512F7AE2-DE65-4354-BD0A-F959CABA6001Q33718813-EBCE0628-9DC8-4FBB-B07C-2510D27E100DQ33718818-03CBD14F-F112-4B0F-954D-9464026D9179Q33718855-2289E23F-1CED-4BB4-AF19-24F33AFD6EA0Q33718917-C38598FA-2CE5-48CC-BF72-6D736E89B17EQ34531769-5FD77B04-D4B3-45F2-BBB4-459AB8FF4BBCQ34531777-FD8B2DFE-9C0F-483D-BC22-B33D197244F8Q34677605-38EC4337-550B-48FF-A3A3-CE749B8006B7Q35776852-9E702452-0499-4ABE-8962-E1D021A849F2Q36311806-F974487C-C2D1-4C34-8A5B-FE193867C88AQ36575926-13D58154-60C0-4AA6-BA75-44991FDCFCEBQ36680149-4DB9BF58-085B-43D9-AFAD-3DA780E57E74Q36848267-A28C74B7-B68C-4A57-922E-D81DDEF16843Q36848272-C685AE53-0987-4987-A28A-0AB2A8ECFA15Q36848277-DAE80EB1-E192-49BC-AD23-02F355EEE37CQ36848282-822B5189-F1DB-4D83-88A7-6582F044142BQ36848287-024BB783-24AF-48E6-BF28-C833BFC100EEQ36848290-F8A86ECB-87E1-4DBE-AC2A-465BFF9A43D5Q36848294-2C070DE2-7AD7-48B9-871D-5C3C533BEB7EQ36848298-D812A8E9-14EA-437A-9D03-4D6271A93401Q36848303-36567D92-CB91-4EA1-97BC-5F84CC8A1BE7Q36848307-DC26B6BA-5707-4F58-BF6B-C19CD731816DQ36848311-54A0E25B-3424-4CC8-8C62-AB3AFA180CA0Q36848315-DFE0C774-3F58-4BE6-ADD4-BF38DAB8AA31Q36848319-3AF450C9-401E-4F17-9979-701DA76E9888
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift van Nature Publishing Group
@nl
wissenschaftliche Fachzeitschrift
@de
name
NPJ schizophrenia
@ast
NPJ schizophrenia
@en
NPJ schizophrenia
@es
NPJ schizophrenia
@nl
type
label
NPJ schizophrenia
@ast
NPJ schizophrenia
@en
NPJ schizophrenia
@es
NPJ schizophrenia
@nl
altLabel
NPJ Schizophr
@en
npj Schizophrenia
@en
prefLabel
NPJ schizophrenia
@ast
NPJ schizophrenia
@en
NPJ schizophrenia
@es
NPJ schizophrenia
@nl
P31
P3181
P1055
P1156
21100854140
P1476
NPJ schizophrenia
@en